Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 30
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Gut ; 64(11): 1744-54, 2015 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-25500202

RESUMO

OBJECTIVE: The colonic microbiota ferment dietary fibres, producing short chain fatty acids. Recent evidence suggests that the short chain fatty acid propionate may play an important role in appetite regulation. We hypothesised that colonic delivery of propionate would increase peptide YY (PYY) and glucagon like peptide-1 (GLP-1) secretion in humans, and reduce energy intake and weight gain in overweight adults. DESIGN: To investigate whether propionate promotes PYY and GLP-1 secretion, a primary cultured human colonic cell model was developed. To deliver propionate specifically to the colon, we developed a novel inulin-propionate ester. An acute randomised, controlled cross-over study was used to assess the effects of this inulin-propionate ester on energy intake and plasma PYY and GLP-1 concentrations. The long-term effects of inulin-propionate ester on weight gain were subsequently assessed in a randomised, controlled 24-week study involving 60 overweight adults. RESULTS: Propionate significantly stimulated the release of PYY and GLP-1 from human colonic cells. Acute ingestion of 10 g inulin-propionate ester significantly increased postprandial plasma PYY and GLP-1 and reduced energy intake. Over 24 weeks, 10 g/day inulin-propionate ester supplementation significantly reduced weight gain, intra-abdominal adipose tissue distribution, intrahepatocellular lipid content and prevented the deterioration in insulin sensitivity observed in the inulin-control group. CONCLUSIONS: These data demonstrate for the first time that increasing colonic propionate prevents weight gain in overweight adult humans. TRIAL REGISTRATION NUMBER: NCT00750438.


Assuntos
Adiposidade/efeitos dos fármacos , Regulação do Apetite/efeitos dos fármacos , Manutenção do Peso Corporal/efeitos dos fármacos , Colo/metabolismo , Peptídeo 1 Semelhante ao Glucagon/metabolismo , Sobrepeso/tratamento farmacológico , Peptídeo YY/metabolismo , Propionatos/administração & dosagem , Células Cultivadas , Colo/citologia , Estudos Cross-Over , Método Duplo-Cego , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Propionatos/farmacologia
2.
Curr Opin Clin Nutr Metab Care ; 17(2): 139-44, 2014 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-24389673

RESUMO

PURPOSE OF REVIEW: Evidence suggests that short-chain fatty acids (SCFAs) derived from microbial metabolism in the gut play a central role in host homeostasis. The present review describes the current understanding and physiological implications of SCFAs derived from microbial metabolism of nondigestible carbohydrates. RECENT FINDINGS: Recent studies indicate a role for SCFAs, in particular propionate and butyrate, in metabolic and inflammatory disorders such as obesity, diabetes and inflammatory bowel diseases, through the activation of specific G-protein-coupled receptors and modification of transcription factors. Established prebiotics, such as fructooligosaccharides and galactooligosaccharides, which support the growth of Bifidobacteria, mainly mediate acetate production. Thus, recent identification of prebiotics which are able to stimulate the production of propionate and butyrate by benign saccharolytic populations in the colon is of interest. SUMMARY: Manipulation of saccharolytic fermentation by prebiotic substrates is beginning to provide information on structure-function relationships relating to the production of SCFAs, which have multiple roles in host homeostasis.


Assuntos
Bactérias/metabolismo , Colo/metabolismo , Ácidos Graxos Voláteis/metabolismo , Inflamação/metabolismo , Microbiota , Oligossacarídeos/metabolismo , Prebióticos , Colo/microbiologia , Ácidos Graxos Voláteis/biossíntese , Humanos , Doenças Inflamatórias Intestinais/metabolismo , Doenças Metabólicas/metabolismo , Receptores Acoplados a Proteínas G/metabolismo , Fatores de Transcrição/metabolismo
3.
Br J Nutr ; 112(8): 1303-14, 2014 Oct 28.
Artigo em Inglês | MEDLINE | ID: mdl-25196744

RESUMO

The energy-salvaging capacity of the gut microbiota from dietary ingredients has been proposed as a contributing factor for the development of obesity. This knowledge generated interest in the use of non-digestible dietary ingredients such as prebiotics to manipulate host energy homeostasis. In the present study, the in vitro response of obese human faecal microbiota to novel oligosaccharides was investigated. Dextrans of various molecular weights and degrees of branching were fermented with the faecal microbiota of healthy obese adults in pH-controlled batch cultures. Changes in bacterial populations were monitored using fluorescent in situ hybridisation and SCFA concentrations were analysed by HPLC. The rate of gas production and total volume of gas produced were also determined. In general, the novel dextrans and inulin increased the counts of bifidobacteria. Some of the dextrans were able to alter the composition of the obese human microbiota by increasing the counts of Bacteroides-Prevotella and decreasing those of Faecalibacterium prausnitzii and Ruminococcus bromii/R. flavefaciens. Considerable increases in SCFA concentrations were observed in response to all substrates. Gas production rates were similar during the fermentation of all dextrans, but significantly lower than those during the fermentation of inulin. Lower total gas production and shorter time to attain maximal gas production were observed during the fermentation of the linear 1 kDa dextran than during the fermentation of the other dextrans. The efficacy of bifidobacteria to ferment dextrans relied on the molecular weight and not on the degree of branching. In conclusion, there are no differences in the profiles between the obese and lean human faecal fermentations of dextrans.


Assuntos
Fármacos Antiobesidade/metabolismo , Bifidobacterium/metabolismo , Dextranos/metabolismo , Fezes/microbiologia , Obesidade/microbiologia , Oligossacarídeos/metabolismo , Prebióticos , Adulto , Fármacos Antiobesidade/química , Fármacos Antiobesidade/uso terapêutico , Bacteroides/classificação , Bacteroides/crescimento & desenvolvimento , Bacteroides/imunologia , Bacteroides/metabolismo , Técnicas de Cultura Celular por Lotes , Bifidobacterium/classificação , Bifidobacterium/crescimento & desenvolvimento , Bifidobacterium/imunologia , Índice de Massa Corporal , Dextranos/química , Dextranos/uso terapêutico , Ácidos Graxos Voláteis/análise , Ácidos Graxos Voláteis/metabolismo , Fermentação , Humanos , Inulina/química , Inulina/metabolismo , Inulina/uso terapêutico , Masculino , Viabilidade Microbiana , Estrutura Molecular , Tipagem Molecular , Peso Molecular , Obesidade/dietoterapia , Oligossacarídeos/química , Oligossacarídeos/uso terapêutico , Prevotella/classificação , Prevotella/crescimento & desenvolvimento , Prevotella/imunologia , Prevotella/metabolismo
4.
Br J Nutr ; 109(11): 1980-9, 2013 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-23116939

RESUMO

The fermentation selectivity of a commercial source of a-gluco-oligosaccharides (BioEcolians; Solabia) was investigated in vitro. Fermentation by faecal bacteria from four lean and four obese healthy adults was determined in anaerobic, pH-controlled faecal batch cultures. Inulin was used as a positive prebiotic control. Samples were obtained at 0, 10, 24 and 36 h for bacterial enumeration by fluorescent in situ hybridisation and SCFA analyses. Gas production during fermentation was investigated in non-pH-controlled batch cultures. a-Gluco-oligosaccharides significantly increased the Bifidobacterium sp. population compared with the control. Other bacterial groups enumerated were unaffected with the exception of an increase in the Bacteroides­Prevotella group and a decrease in Faecalibacterium prausnitzii on both a-gluco-oligosaccharides and inulin compared with baseline. An increase in acetate and propionate was seen on both substrates. The fermentation of a-gluco-oligosaccharides produced less total gas at a more gradual rate of production than inulin. Generally, substrates fermented with the obese microbiota produced similar results to the lean fermentation regarding bacteriology and metabolic activity. No significant difference at baseline (0 h) was detected between the lean and obese individuals in any of the faecal bacterial groups studied.


Assuntos
Bactérias/metabolismo , Fezes/microbiologia , Obesidade/microbiologia , Oligossacarídeos/metabolismo , Adulto , Bactérias/classificação , Fermentação , Humanos , Oligossacarídeos/química
5.
Appl Microbiol Biotechnol ; 97(13): 5743-52, 2013 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-23624658

RESUMO

The in vitro fermentation of several purified galacto-oligosaccharides (GOS), specifically the trisaccharides 4'-galactosyl-lactose and 6'-galactosyl-lactose and a mixture of the disaccharides 6-galactobiose and allolactose, was carried out. The bifidogenic effect of GOS at 1% (w/v) was studied in a pH-controlled batch culture fermentation system inoculated with healthy adult human faeces. Results were compared with those obtained with a commercial GOS mixture (Bimuno-GOS). Changes in bacterial populations measured through fluorescence in situ hybridization and short-chain fatty acid (SCFA) production were determined. Bifidobacteria increased after 10-h fermentation for all the GOS substrates, but the changes were only statistically significant (P<0.05) for the mixture of disaccharides and Bimuno-GOS. Acetic acid, whose formation is consistent with bifidobacteria metabolism, was the major SCFA synthesized. The acetate concentration at 10 h was similar with all the substrates (45-50 mM) and significantly higher than the observed for formic, propionic and butyric acids. All the purified GOS could be considered bifidogenic under the assayed conditions, displaying a selectivity index in the range 2.1-3.0, which was slightly lower than the determined for the commercial mixture Bimuno-GOS.


Assuntos
Bactérias/metabolismo , Fezes/microbiologia , Trissacarídeos/metabolismo , Bactérias/genética , Biota , Ácidos Graxos Voláteis/análise , Fermentação , Humanos , Hibridização in Situ Fluorescente
6.
J Agric Food Chem ; 70(29): 9048-9056, 2022 Jul 27.
Artigo em Inglês | MEDLINE | ID: mdl-35830712

RESUMO

This study was conducted to investigate the sweetness intensity and the potential fecal microbiome modulation of galactooligosaccharides in combination with enzymatically modified mogrosides (mMV-GOS), both generated through a patented single-pot synthesis. Sweetness intensity was performed in vivo by trained sensory panelists. The impact on the human fecal microbiome was evaluated by in vitro pH-controlled batch fermentation, and bacterial populations and organic acid concentrations were measured by qPCR and GC-FID, respectively. Significant growth (p ≤ 0.05) during the fermentation at 10 h of bacterial populations includes Bifidobacterium (8.49 ± 0.44 CFU/mL), Bacteroides (9.73 ± 0.32 CFU/mL), Enterococcus (8.17 ± 0.42 CFU/mL), and Clostridium coccoides (6.15 ± 0.11 CFU/mL) as compared to the negative control counts for each bacterial group (7.94 ± 0.27, 7.84 ± 1.11, 7.52 ± 0.37, and 5.81 ± 0.08 CFU/mL, respectively) at the same time of fermentation. Likewise, the corresponding significant increase in production of SCFA in mMV-GOS at 10 h of fermentation, mainly seen in acetate (20.32 ± 2.56 mM) and propionate (9.49 ± 1.44 mM) production compared to a negative control at the same time (8.15 ± 1.97 and 1.86 ± 0.24 mM), is in line with a positive control (short-chain fructooligosaccharides; 46.74 ± 12.13 and 6.51 ± 1.91 mM, respectively) revealing a selective fermentation. In conclusion, these substrates could be considered as novel candidate prebiotic sweeteners, foreseeing a feasible and innovative approach targeting the sucrose content reduction in food. This new ingredient could provide health benefits when evaluated in human studies by combining sweetness and prebiotic fiber functionality.


Assuntos
Ácidos Graxos Voláteis , Prebióticos , Bactérias/genética , Bifidobacterium , Fezes/microbiologia , Fermentação , Humanos , Oligossacarídeos , Edulcorantes
7.
Appl Environ Microbiol ; 77(16): 5747-54, 2011 Aug 15.
Artigo em Inglês | MEDLINE | ID: mdl-21724897

RESUMO

To evaluate the fermentation properties of oligosaccharides derived from pectins and their parent polysaccharides, a 5-ml-working-volume, pH- and temperature-controlled fermentor was tested. Six pectic oligosaccharides representing specific substructures found within pectins were prepared. These consisted of oligogalacturonides (average degrees of polymerization [DP] of 5 and 9), methylated oligogalacturonides (average DP of 5), oligorhamnogalacturonides (average DP of 10 as a disaccharide unit of galacturonic acid and rhamnose), oligogalactosides (average DP of 5), and oligoarabinosides (average DP of 6). The influence of these carbohydrates on the human fecal microbiota was evaluated. Use of neutral sugar fractions resulted in an increase in Bifidobacterium populations and gave higher organic acid yields. The Bacteroides-Prevotella group significantly increased on all oligosaccharides except oligogalacturonides with an average DP of 5. The most selective substrates for bifidobacteria were arabinan, galactan, oligoarabinosides, and oligogalactosides.


Assuntos
Bifidobacterium/metabolismo , Reatores Biológicos/microbiologia , Fezes/microbiologia , Fermentação , Pectinas/metabolismo , Análise de Variância , Arabidopsis/química , Carga Bacteriana/métodos , Bacteroides/metabolismo , Reatores Biológicos/normas , Fracionamento Químico/métodos , Ácidos Graxos Voláteis/metabolismo , Ácidos Hexurônicos/metabolismo , Humanos , Hibridização in Situ Fluorescente , Oligossacarídeos/metabolismo , Ramnose/metabolismo , Sementes/química
8.
Appl Environ Microbiol ; 77(15): 5307-15, 2011 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-21666027

RESUMO

The role of structure and molecular weight in fermentation selectivity in linear α-1,6 dextrans and dextrans with α-1,2 branching was investigated. Fermentation by gut bacteria was determined in anaerobic, pH-controlled fecal batch cultures after 36 h. Inulin (1%, wt/vol), which is a known prebiotic, was used as a control. Samples were obtained at 0, 10, 24, and 36 h of fermentation for bacterial enumeration by fluorescent in situ hybridization and short-chain fatty acid analyses. The gas production of the substrate fermentation was investigated in non-pH-controlled, fecal batch culture tubes after 36 h. Linear and branched 1-kDa dextrans produced significant increases in Bifidobacterium populations. The degree of α-1,2 branching did not influence the Bifidobacterium populations; however, α-1,2 branching increased the dietary fiber content, implying a decrease in digestibility. Other measured bacteria were unaffected by the test substrates except for the Bacteroides-Prevotella group, the growth levels of which were increased on inulin and 6- and 70-kDa dextrans, and the Faecalibacterium prausnitzii group, the growth levels of which were decreased on inulin and 1-kDa dextrans. A considerable increase in short-chain fatty acid concentration was measured following the fermentation of all dextrans and inulin. Gas production rates were similar among all dextrans tested but were significantly slower than that for inulin. The linear 1-kDa dextran produced lower total gas and shorter time to attain maximal gas production compared to those of the 70-kDa dextran (branched) and inulin. These findings indicate that dextrans induce a selective effect on the gut flora, short-chain fatty acids, and gas production depending on their length.


Assuntos
Dextranos/metabolismo , Fezes/microbiologia , Fermentação/fisiologia , Intestinos/microbiologia , Anaerobiose , Bacteroides/metabolismo , Bifidobacterium/metabolismo , Ácidos Graxos Voláteis/biossíntese , Humanos , Hibridização in Situ Fluorescente , Inulina/metabolismo , Prevotella/metabolismo , Ruminococcus/metabolismo
9.
J Agric Food Chem ; 69(3): 1011-1019, 2021 Jan 27.
Artigo em Inglês | MEDLINE | ID: mdl-33428404

RESUMO

Luo Han Guo fruit extract (Siraitia grosvenorii), mainly composed of mogroside V (50%), could be considered a suitable alternative to free sugars; however, its commercial applications are limited by its unpleasant off-notes. In the present work, a central composite design method was employed to optimize the transglycosylation of a mogroside extract using cyclodextrin glucosyltransferases (CGTases) from three different bacteriological sources (Paenibacillus macerans, Geobacillus sp., and Thermoanaerobacter sp.) considering various experimental parameters such as maltodextrin and mogroside concentration, temperature, time of reaction, enzymatic activity, and pH. Product structures were determined by liquid chromatography coupled to a diode-array detector (LC-DAD), liquid chromatography-electrospray ionization-mass spectrometry (LC-ESI-MS), and matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS). Sensory analysis of glucosylated mogrosides showed an improvement in flavor attributes relevant to licorice flavor and aftereffect. Consequently, an optimum methodology was developed to produce new modified mogrosides more suitable when formulating food products as free sugar substitutes.


Assuntos
Proteínas de Bactérias/química , Cucurbitaceae/química , Glucosídeos/biossíntese , Glucosiltransferases/química , Extratos Vegetais/química , Edulcorantes/síntese química , Biocatálise , Cromatografia Líquida de Alta Pressão , Frutas/química , Geobacillus/enzimologia , Glucosídeos/química , Paenibacillus/enzimologia , Extratos Vegetais/síntese química , Espectrometria de Massas por Ionização por Electrospray , Edulcorantes/química , Thermoanaerobacter/enzimologia
10.
J Antimicrob Chemother ; 65(12): 2556-65, 2010 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-20852272

RESUMO

OBJECTIVES: Rifaximin, a rifamycin derivative, has been reported to induce clinical remission of active Crohn's disease (CD), a chronic inflammatory bowel disorder. In order to understand how rifaximin affects the colonic microbiota and its metabolism, an in vitro human colonic model system was used in this study. METHODS: We investigated the impact of the administration of 1800 mg/day of rifaximin on the faecal microbiota of four patients affected by colonic active CD [Crohn's disease activity index (CDAI > 200)] using a continuous culture colonic model system. We studied the effect of rifaximin on the human gut microbiota using fluorescence in situ hybridization, quantitative PCR and PCR-denaturing gradient gel electrophoresis. Furthermore, we investigated the effect of the antibiotic on microbial metabolic profiles, using (1)H-NMR and solid phase microextraction coupled with gas chromatography/mass spectrometry, and its potential genotoxicity and cytotoxicity, using Comet and growth curve assays. RESULTS: Rifaximin did not affect the overall composition of the gut microbiota, whereas it caused an increase in concentration of Bifidobacterium, Atopobium and Faecalibacterium prausnitzii. A shift in microbial metabolism was observed, as shown by increases in short-chain fatty acids, propanol, decanol, nonanone and aromatic organic compounds, and decreases in ethanol, methanol and glutamate. No genotoxicity or cytotoxicity was attributed to rifaximin, and conversely rifaximin was shown to have a chemopreventive role by protecting against hydrogen peroxide-induced DNA damage. CONCLUSIONS: We demonstrated that rifaximin, while not altering the overall structure of the human colonic microbiota, increased bifidobacteria and led to variation of metabolic profiles associated with potential beneficial effects on the host.


Assuntos
Anti-Infecciosos/farmacologia , Técnicas Bacteriológicas/métodos , Colo/microbiologia , Doença de Crohn/microbiologia , Metagenoma/efeitos dos fármacos , Rifamicinas/farmacologia , Bifidobacterium/efeitos dos fármacos , Bifidobacterium/crescimento & desenvolvimento , Meios de Cultura , Eletroforese em Gel de Gradiente Desnaturante , Ecossistema , Fezes/microbiologia , Humanos , Hibridização in Situ Fluorescente , Reação em Cadeia da Polimerase , Rifaximina
11.
Br J Nutr ; 104(7): 1007-17, 2010 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-20591206

RESUMO

There is growing interest in the use of inulins as substrates for the selective growth of beneficial gut bacteria such as bifidobacteria and lactobacilli because recent studies have established that their prebiotic effect is linked to several health benefits. In the present study, the impact of a very-long-chain inulin (VLCI), derived from globe artichoke (Cynara scolymus), on the human intestinal microbiota compared with maltodextrin was determined. A double-blind, cross-over study was carried out in thirty-two healthy adults who were randomised into two groups and consumed 10 g/d of either VLCI or maltodextrin, for two 3-week study periods, separated by a 3-week washout period. Numbers of faecal bifidobacteria and lactobacilli were significantly higher upon VLCI ingestion compared with the placebo. Additionally, levels of Atopobium group significantly increased, while Bacteroides-Prevotella numbers were significantly reduced. No significant changes in faecal SCFA concentrations were observed. There were no adverse gastrointestinal symptoms apart from a significant increase in mild and moderate bloating upon VLCI ingestion. These observations were also confirmed by in vitro gas production measurements. In conclusion, daily consumption of VLCI extracted from globe artichoke exerted a pronounced prebiotic effect on the human faecal microbiota composition and was well tolerated by all volunteers.


Assuntos
Bifidobacterium/efeitos dos fármacos , Colo/microbiologia , Cynara scolymus/química , Fibras na Dieta/administração & dosagem , Inulina/farmacologia , Extratos Vegetais/farmacologia , Prebióticos , Adulto , Bifidobacterium/crescimento & desenvolvimento , Estudos Cross-Over , Método Duplo-Cego , Fezes/química , Feminino , Gases , Humanos , Inflorescência , Inulina/efeitos adversos , Lactobacillus/efeitos dos fármacos , Lactobacillus/crescimento & desenvolvimento , Masculino , Extratos Vegetais/efeitos adversos , Polissacarídeos , Valores de Referência , Adulto Jovem
12.
Foods ; 9(12)2020 Nov 26.
Artigo em Inglês | MEDLINE | ID: mdl-33256263

RESUMO

To improve flavor profiles, three cyclodextrin glucosyltransferases (CGTases) from different bacteriological sources, Paenibacillus macerans, Geobacillus sp. and Thermoanaerobacter sp., were used with an extract of steviol glycosides (SVglys) and rebaudioside A (RebA) as acceptor substrates in two parallel sets of reactions. A central composite experimental design was employed to maximize the concentration of glucosylated species synthesized, considering temperature, pH, time of reaction, enzymatic activity, maltodextrin concentration and SVglys/RebA concentration as experimental factors, together with their interactions. Liquid chromatography coupled to a diode-array detector (LC-DAD), liquid chromatography-mass spectrometry (LC-ESI-MS) and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) were used to characterize and identify the chemical structures obtained along the optimization. To assess the impact on the sensory properties, a sensory analysis was carried out with a group of panelists that evaluated up to 16 sensorial attributes. CGTase transglucosylation of the C-13 and/or C-19 led to the addition of up to 11 glucose units to the steviol aglycone, which meant the achievement of enhanced sensory profiles due to a diminution of bitterness and licorice appreciations. The outcome herein obtained supposes the development of new potential alternatives to replace free sugars with low-calorie sweeteners with added health benefits.

13.
3 Biotech ; 9(3): 93, 2019 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-30800604

RESUMO

Copra meal hydrolysate (CMH) is obtained by hydrolyzing defatted copra meal with ß-mannanase from Bacillus circulans NT 6.7. In this study, we investigated the resistance of CMH to upper gastrointestinal tract digestion and the fecal fermentation profiles of CMH. Fecal slurries from four healthy human donors were used as inocula, and fructooligosaccharides (FOS) were used as a positive prebiotic control. Fecal batch cultures were performed at 37 °C under anaerobic conditions. Samples were collected at 0, 10, 24 and 34 h for bacterial enumeration via fluorescent in situ hybridization and organic acid (OA) analysis. In vitro gastric stomach and human pancreatic α-amylase simulations demonstrated that CMH was highly resistant to hydrolysis. Acetate was the main fermentation product of all the substrates. The proportions of acetate production of the total OAs from FOS, CMH and yeast mannooligosaccharides (MOS) after 34 h of fermentation did not significantly differ (69.76, 65.24 and 53.93%, respectively). At 24 h of fermentation, CMH promoted the growth of Lactobacillus and Bifidobacterium groups (P < 0.01) and did not significantly differ from the results obtained using FOS. The results of in vitro fecal fermentation of CMH indicate that CMH can promote the growth of beneficial bacteria.

14.
FEMS Microbiol Ecol ; 66(3): 516-27, 2008 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-18673391

RESUMO

Synbiotics are recognized means of modulating gut microbiota composition and activities. However, whether synbiotics are superior to prebiotics and probiotics alone in moderating the gut microbiota towards a purportedly healthy composition has not been determined. Eight selected synbiotics (short-chain fructooligosaccharides or fructooligosaccharides, each combined with one of four probiotics, Lactobacillus fermentum ME-3, Lactobacillus plantarum WCFS1, Lactobacillus paracasei 8700:2 or Bifidobacterium longum 46) were added to 24-h pH-controlled anaerobic faecal batch cultures. The prebiotic and probiotic components were also tested alone to determine their respective role within the synbiotic for modulation of the faecal microbiota. Effects upon major groups of the microbiota were evaluated using FISH. Rifampicin variant probiotic strains were used to assess probiotic levels. Synbiotic and prebiotics increased bifidobacteria and the Eubacterium rectale-Clostridium coccoides group. Lower levels of Escherichia coli were retrieved with these combinations after 5 and 10 h of fermentation. Probiotics alone had little effect upon the groups, however. Multivariate analysis revealed that the effect of synbiotics differed from the prebiotics as higher levels of Lactobacillus-Enterococcus were observed when the probiotic was stimulated by the prebiotic component. Here, the synbiotic approach was more effective than prebiotic or probiotic alone to modulate the gut microbiota.


Assuntos
Bactérias/crescimento & desenvolvimento , Bactérias/metabolismo , Biodiversidade , Fezes/microbiologia , Probióticos , Fermentação , Bacilos Gram-Positivos Asporogênicos/crescimento & desenvolvimento , Bacilos Gram-Positivos Asporogênicos/metabolismo , Humanos , Hibridização in Situ Fluorescente , Oligossacarídeos/metabolismo , Análise de Componente Principal , Especificidade da Espécie
15.
Front Microbiol ; 9: 1153, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-29922256

RESUMO

Bile acids, the products of concerted host and gut bacterial metabolism, have important signaling functions within the mammalian metabolic system and a key role in digestion. Given the complexity of the mega-variate bacterial community residing in the gastrointestinal tract, studying associations between individual bacterial genera and bile acid processing remains a challenge. Here, we present a novel in vitro approach to determine the bacterial genera associated with the metabolism of different primary bile acids and their potential to contribute to inter-individual variation in this processing. Anaerobic, pH-controlled batch cultures were inoculated with human fecal microbiota and treated with individual conjugated primary bile acids (500 µg/ml) to serve as the sole substrate for 24 h. Samples were collected throughout the experiment (0, 5, 10, and 24 h) and the bacterial composition was determined by 16S rRNA gene sequencing and the bile acid signatures were characterized using a targeted ultra-performance liquid chromatography-mass spectrometry (UPLC-MS) approach. Data fusion techniques were used to identify statistical bacterial-metabolic linkages. An increase in gut bacteria associated bile acids was observed over 24 h with variation in the rate of bile acid metabolism across the volunteers (n = 7). Correlation analysis identified a significant association between the Gemmiger genus and the deconjugation of glycine conjugated bile acids while the deconjugation of taurocholic acid was associated with bacteria from the Eubacterium and Ruminococcus genera. A positive correlation between Dorea and deoxycholic acid production suggest a potential role for this genus in cholic acid dehydroxylation. A slower deconjugation of taurocholic acid was observed in individuals with a greater abundance of Parasutterella and Akkermansia. This work demonstrates the utility of integrating compositional (metataxonomics) and functional (metabonomics) systems biology approaches, coupled to in vitro model systems, to study the biochemical capabilities of bacteria within complex ecosystems. Characterizing the dynamic interactions between the gut microbiota and the bile acid pool enables a greater understanding of how variation in the gut microbiota influences host bile acid signatures, their associated functions and their implications for health.

16.
PLoS One ; 12(12): e0187964, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-29228000

RESUMO

Coronary heart disease (CHD) is one of the major causes of death and disability in industrialised countries, with elevated blood cholesterol an established risk factor. Total plasma cholesterol reduction in populations suffering from primary hypercholesterolemia may lower CHD incidence. This study investigated the cholesterol reducing capacity of Lactobacillus plantarum ECGC 13110402, a strain selected for its high bile salt hydrolase activity, in 49 normal to mildly hypercholesterolaemic adults. Primary efficacy outcomes included effect on blood lipids (total cholesterol (TC), low density lipoproteins (LDL-C), high density lipoproteins (HDL-C) and triacylgycerides (TAG), inflammatory biomarkers and occurrence/severity of gastrointestinal side effects to establish safety and tolerance of the intervention. Secondary outcomes included blood pressure, immune biomarkers, gut microbiota characterisation and metabonome changes. The study was run in a parallel, double blind, placebo controlled, randomised design in which the active group ingested 2x109 CFU encapsulated Lactobacillus plantarum ECGC 13110402 twice daily. Daily ingestion of the active treatment resulted in a statistically significant reduction in LDL-C in volunteers with baseline TC<5mM during the 0-12 week period (13.9%, P = 0.030), a significant reduction in TC in volunteers with baseline TC≥6mM in the 0-6 week period (37.6%, P = 0.045), a significant decrease in TAG (53.9% P = 0.030) and an increase in HDL-C (14.7%, P = 0.007) in the over 60 years population in the 6-12 week period. A statistically significant reduction in systolic blood pressure was also observed across the active study group in the 6-12-week period (6.6%, P = 0.003). No impact on gastrointestinal function and side effects was observed during the study. Similar to blood and urine metabonomic analyses, faecal metagenomics did not reveal significant changes upon active or placebo intake. The results of this study suggest that Lactobacillus plantarum ECGC 13110402 is a well-tolerated, natural probiotic, that may be used as an alternative or supplement to existing treatments to reduce cardiovascular risk. TRIAL REGISTRATION: Clinical trials.gov NCT03263104.


Assuntos
Hipercolesterolemia/terapia , Lactobacillus plantarum , Adolescente , Adulto , Biomarcadores/sangue , Colesterol/sangue , DNA Ribossômico/genética , Método Duplo-Cego , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Placebos , RNA Ribossômico 16S/genética , Triglicerídeos/sangue , Adulto Jovem
17.
J Agric Food Chem ; 65(48): 10505-10513, 2017 Dec 06.
Artigo em Inglês | MEDLINE | ID: mdl-29131629

RESUMO

This work addresses the high-yield and fast enzymatic production of theanderose, a naturally occurring carbohydrate, also known as isomaltosucrose, whose chemical structure determined by NMR is α-d-glucopyranosyl-(1 → 6)-α-d-glucopyranosyl-(1 → 2)-ß-d-fructofuranose. The ability of isomaltose to act as an acceptor in the Bacillus subtilis CECT 39 levansucrase-catalyzed transfructosylation reaction to efficiently produce theanderose in the presence of sucrose as a donor is described by using four different sucrose:isomaltose concentration ratios. The maximum theanderose concentration ranged from 122.4 to 130.4 g L-1, was obtained after only 1 h and at a moderate temperature (37 °C), leading to high productivity (109.7-130.4 g L-1h-1) and yield (up to 37.3%) values. The enzymatic synthesis was highly regiospecific, since no other detectable acceptor reaction products were formed. The development of efficient and cost-effective procedures for the biosynthesis of unexplored but appealing oligosaccharides as potential sweeteners, such as theanderose, could help to expand its potential applications which are currently limited by their low availability.


Assuntos
Bacillus subtilis/enzimologia , Proteínas de Bactérias/metabolismo , Hexosiltransferases/metabolismo , Trissacarídeos/metabolismo , Bacillus subtilis/química , Bacillus subtilis/genética , Proteínas de Bactérias/química , Proteínas de Bactérias/genética , Biocatálise , Frutanos/química , Frutanos/metabolismo , Cromatografia Gasosa-Espectrometria de Massas , Hexosiltransferases/química , Hexosiltransferases/genética , Oligossacarídeos/química , Oligossacarídeos/metabolismo , Especificidade por Substrato , Sacarose/química , Sacarose/metabolismo , Trissacarídeos/química
18.
Carbohydr Polym ; 136: 466-73, 2016 Jan 20.
Artigo em Inglês | MEDLINE | ID: mdl-26572377

RESUMO

This work evaluates the bifidogenic potential of substituted xylo-oligosaccharides (XOS) obtained from a lignocellulosic feedstock (corn straw). Autohydrolysis was used to selectively hydrolyse the xylan-rich hemicellulosic fraction and the soluble oligosaccharides were purified by gel filtration chromatography. Selected oligosaccharides fractions within the target ranges of polymerization degree (4-6 and 9-21, samples S1 and S2, respectively) were characterized and their bifidogenic potential was investigated by in vitro fermentations using human fecal inocula. Bacterial growth was assessed by fluorescent in situ hybridization (FISH). XOS consumption and short-chain fatty acids (SCFA) production were evaluated and compared with commercial oligosaccharides. Under the tested conditions, all the substrates were utilized by the microbiota, and fermentation resulted in increased bifidobacteria populations. Samples S1 and S2 increased bifidobacteria populations and the production profile of SCFA was similar for XOS samples and commercial oligosaccharides although XOS samples displayed the highest concentration of SCFA on longer fermentation times.


Assuntos
Celulose/química , Fermentação , Glucuronatos/química , Microbiologia Industrial/métodos , Oligossacarídeos/química , Zea mays/química , Bifidobacterium/crescimento & desenvolvimento , Bifidobacterium/isolamento & purificação , Bifidobacterium/metabolismo , Celulose/metabolismo , Fezes/microbiologia , Glucuronatos/metabolismo , Humanos , Hidrólise , Oligossacarídeos/metabolismo
19.
J Br Menopause Soc ; 9(2): 69-74, 2003 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12844428

RESUMO

Functional foods such as probiotics, prebiotics and nutraceuticals are of extreme interest to researchers. There is growing evidence that these food ingredients may improve and in some cases treat certain conditions that are implicated in women's health. The use of probiotics (live, beneficial bacteria) in improving gastrointestinal and non-gastrointestinal tract conditions such as irritable bowel syndrome, candidiasis and other female urogenital tract conditions are reviewed. Emphasis is also given to the importance of prebiotics (non-digestible food ingredients) in osteoporosis management and alleviation of menopausal symptoms and reducing the onset of cancer.


Assuntos
Menopausa , Fitoterapia , Probióticos , Feminino , Humanos
20.
Carbohydr Polym ; 87(1): 846-852, 2012 Jan 04.
Artigo em Inglês | MEDLINE | ID: mdl-34663045

RESUMO

Lactic acid bacteria (LAB) selected based on high EPSs production yields of 14, 7.6, 4.9 and 5g/L in sucrose containing MRS broth were identified as Weissella cibaria, Weissella confusa, Lactobacillus plantarum and Pediococcus pentosaceus, respectively based on their 16S rDNA sequences. EPSs produced by these strains did not stimulate secretion of interleukin (IL)-8, and were resistant to stomach acid and human pancreatic amylase. In pure culture system, only Bifidobacterium bifidum DSM 20456 exhibited the ability to utilize these EPSs as carbon sources but not L. plantarum TISTR 875 and Lactobacillus acidophilus TISTR 1034. EPSs from W. cibaria exhibited strong bifidogenic effect in the mixed-culture of human fecal microflora using the three-stage fermentation model. In the transverse and distal colon, bifidobacteria and lactobacilli as well as acetate and propionate increased significantly. Butyrate slightly decreased in the proximal colon region after feeding EPSs, but increased in the distal region.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA